Addex Therapeutics (ADXN) Return on Assets (2020 - 2026)
Addex Therapeutics (ADXN) posted Return on Assets of 0.0% for Q1 2026, down 66.52% sequentially from 0.0% in Q4 2025, and down 2.0% YoY from 0.0% in Q1 2025.
Addex Therapeutics (ADXN) Return on Assets (2020 - 2026) Analysis & Trends
Addex Therapeutics has reported Return on Assets for 7 years, with the latest figure at 0.0% in Q1 2026.
- Quarterly Return on Assets fell 2.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (down 2.0% YoY) and the FY2025 annual result came in at 0.0%, down 2.0% from the prior year.
- Return on Assets slipped to 0.0% in Q1 2026 per ADXN's latest filing, from 0.0% in the prior quarter.
- Over five years, Return on Assets peaked at 0.01% in Q1 2025 and troughed at 0.04% in Q1 2024.
- A 5-year average of 0.01% and a median of 0.0% in 2023 frame the typical range for Return on Assets.
- The sharpest annual moves came in 2024 and 2025: Return on Assets declined 3 bps in 2024, then climbed 5 bps in 2025.
- Over 5 years, Return on Assets stood at 0.01% in 2022, then slumped by 157 bps to 0.03% in 2023, then soared by 139 bps to 0.01% in 2024, then sank by 117 bps to 0.0% in 2025, then slumped by 67 bps to 0.0% in 2026.
- According to Business Quant data, Return on Assets over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.50 Bn | 131.65 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.10 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.59 Bn | 60.41 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.75 Bn | 51.62 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 27.80 Bn | 9.41 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 0.00% |
| 10 | Addex Therapeutics | 508.40 Mn | 508.40 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.01% |
| Dec 31, 2024 | 0.01% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | -0.04% |
| Dec 31, 2023 | -0.03% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.02% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |
| Jun 30, 2021 | -0.01% |